DRUG · Unmapped registry intervention
Islet cell transplantation
Find medicine records ·
Find other trials using this name
Clinical trial
Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
NCT00530686
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Islet Cell Transplantationunresolved
Interventions
Sponsors & collaborators
Baylor Research Institutelead sponsor
Baylor Health Care Systemcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00530686 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.